The site with the highest decrease in glycosylation is at N330 of versican core protein (VCAN); a total of 23, 18, and 10 different glycans were identified on this site in normal, asymptomatic, and symptomatic AD samples, respectively (supplemental Table S14). This evidence concerns the gene VCAN and Alzheimer disease.